Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine pharmacokinetics in obstructive jaundice
ChiCTR-IPR-15007572Phase 4Recruiting
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in cholangiocarcinoma (CCA) and pancreatic cancer (PC) (2 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Plasma drug concentration. Started Dec 2015; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cholangiocarcinoma (CCA)pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR-IPR-15007572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007572.